MARKET

ABBV

ABBV

Abbvie Inc
NYSE
223.43
+4.41
+2.01%
After Hours: 224.00 +0.57 +0.26% 19:56 02/06 EST
OPEN
218.75
PREV CLOSE
219.02
HIGH
225.82
LOW
218.50
VOLUME
6.07M
TURNOVER
--
52 WEEK HIGH
241.12
52 WEEK LOW
159.05
MARKET CAP
394.89B
P/E (TTM)
168.59
1D
5D
1M
3M
1Y
5Y
1D
AbbVie Seeks Rinvoq Vitiligo Approval And Extends Immunology Growth Story
Simply Wall St · 18h ago
Earnings Scorecard: 22 out of 23 healthcare firms deliver EPS wins this week
Seeking Alpha · 1d ago
Big Pharma's Earnings Week: Strong Performance, Obesity Wars, LOE Management And More
Seeking Alpha · 1d ago
Dividend Champion, Contender, And Challenger Highlights: Week Of February 8
Seeking Alpha · 1d ago
CVS Caremark Replaces Amgen And Eli Lilly's Branded Drugs, Expands Biosimilar Strategy For Weak Bone Disorder
Benzinga · 1d ago
AbbVie (ABBV) One Off US$5.0b Loss Tests Bullish High P/E Valuation Narratives
Simply Wall St · 2d ago
Balanced Risk-Reward and Fading Upside Visibility Keep AbbVie at Market-Perform (Hold) with $225 Target
TipRanks · 2d ago
AbbVie (ABBV) Receives a Buy from Guggenheim
TipRanks · 2d ago
More
About ABBV
AbbVie Inc. is a global, diversified research-based biopharmaceutical company. It is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. Its product portfolio includes Immunology, Oncology, Aesthetics, Neuroscience, Eye Care and Other Key Products. Immunology products include rheumatology, dermatology and gastroenterology. Oncology products include Imbruvica, Venclexta/Venclyxto, Elahere and Epkinly. Aesthetics portfolio consists of facial injectables, plastics and regenerative medicine, body contouring, and skincare products. Its Neuroscience products include Botox Therapeutic, Vraylar, Duopa and Duodopa, Ubrelvy, and Qulipta. Eye Care products include Ozurdex, Lumigan/Ganfort, Alphagan/Combigan, Restasis, and other eye care. Other key products include Mavyret/Maviret, Creon, and Linzess/Constella. Its investigational candidate, bretisilocin, is for the treatment of patients with moderate-to-severe major depressive disorder (MDD).

Webull offers AbbVie Inc stock information, including NYSE: ABBV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ABBV stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ABBV stock methods without spending real money on the virtual paper trading platform.